January 6, 2025 · Form 4 insider transaction
Power Sean A sold 10,021 shares of TG Therapeutics, Inc. at $28.53 per share, a transaction worth $285.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
In connection with the vesting of 45,000 shares on January 1, 2025, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.; Includes shares of restricted Common Stock, which vest over various time periods.